SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 9 Jun · 19:14 IST

Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹3169.00
prior close
₹3175.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.4+0.5+0.7-0.4-1.6+2.7+4.9+4.3+5.3+9.7+7.8
Up moveDown movePending
AI summary

Sanofi India has submitted a disclosure to the stock exchanges under Regulation 30 of the SEBI Listing Regulations, which is the standard mechanism companies use to inform the market about material events or corporate developments. The specific details of the intimation are not contained in the headline provided. Reg 30 filings typically cover events such as board changes, mergers, acquisitions, financial results, dividend announcements, or changes in capital structure. Retail investors should look at the attached document to understand the exact nature of the disclosure.

Likely market impact

Since the specific content of the disclosure is not available in the headline, the immediate impact on shareholders or the stock is unclear. Investors should review the full filing to assess whether it contains any material information that could affect the stock price or their investment decision.